These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31004781)

  • 1. Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: The United States experience from 2007 to 2014.
    Saba S; McLaughlin T; He M; Althouse A; Mulukutla S; Hernandez I
    Heart Rhythm; 2019 Jul; 16(7):1065-1071. PubMed ID: 31004781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
    JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy.
    Leyva F; Zegard A; Umar F; Taylor RJ; Acquaye E; Gubran C; Chalil S; Patel K; Panting J; Marshall H; Qiu T
    Europace; 2018 Nov; 20(11):1804-1812. PubMed ID: 29697764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy.
    Leyva F; Zegard A; Acquaye E; Gubran C; Taylor R; Foley PWX; Umar F; Patel K; Panting J; Marshall H; Qiu T
    J Am Coll Cardiol; 2017 Sep; 70(10):1216-1227. PubMed ID: 28859784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Anantha Narayanan M; Vakil K; Reddy YN; Baskaran J; Deshmukh A; Benditt DG; Adabag S
    JACC Clin Electrophysiol; 2017 Sep; 3(9):962-970. PubMed ID: 29759721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy.
    Doran B; Mei C; Varosy PD; Kao DP; Saxon LA; Feldman AM; DeMets D; Bristow MR
    JACC Heart Fail; 2021 Jun; 9(6):439-449. PubMed ID: 33992570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy in ischemic vs nonischemic cardiomyopathy patients.
    Abu Daya H; Alam MB; Adelstein E; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
    Heart Rhythm; 2014 Apr; 11(4):614-9. PubMed ID: 24462657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ECG score to predict ICD therapies in patients with nonischemic cardiomyopathy and primary prophylactic CRT-D].
    Grett M; Christ M; Röing Gen Nölke JP; Trappe HJ
    Herzschrittmacherther Elektrophysiol; 2017 Mar; 28(1):48-53. PubMed ID: 28204917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S; Asad Z; Reynolds D
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-specific clinical outcomes after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.
    Wang NC; Mezu-Chukwu U; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Shalaby AA; Voigt AH; Saba S
    Ann Noninvasive Electrocardiol; 2019 Jul; 24(4):e12641. PubMed ID: 30919524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
    Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B
    Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
    Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy-a nationwide cohort study.
    Farouq M; Rorsman C; Marinko S; Mörtsell D; Chaudhry U; Wang L; Platonov PG; Borgquist R
    Europace; 2023 Jul; 25(7):. PubMed ID: 37392462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: A propensity score matched analysis.
    Liang Y; Wang J; Yu Z; Zhang M; Pan L; Nie Y; Su Y; Ge J
    J Cardiol; 2020 Apr; 75(4):432-438. PubMed ID: 31570188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease.
    Friedman DJ; Singh JP; Curtis JP; Tang WHW; Bao H; Spatz ES; Hernandez AF; Patel UD; Al-Khatib SM
    J Am Coll Cardiol; 2015 Dec; 66(23):2618-2629. PubMed ID: 26670062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.